The global diagnostic testing market size is calculated at USD 207.96 billion in 2025 and is forecasted to reach around USD 272.98 billion by 2034, accelerating at a CAGR of 3% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Ages
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Eleven Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Diagnostic Testing Market, by Type
7.1.1. Clinical Diagnostic
7.1.1.1. Market Revenue and Forecast
7.1.2. Home Diagnostic
7.1.2.1. Market Revenue and Forecast
8.1. Diagnostic Testing Market, by Application
8.1.1. Cardiology
8.1.1.1. Market Revenue and Forecast
8.1.2. Oncology
8.1.2.1. Market Revenue and Forecast
8.1.3. Neurology
8.1.3.1. Market Revenue and Forecast
8.1.4. Orthopedics
8.1.4.1. Market Revenue and Forecast
8.1.5. Gastroenterology
8.1.5.1. Market Revenue and Forecast
8.1.6. Gynecology
8.1.6.1. Market Revenue and Forecast
8.1.7. Odontology
8.1.8.1. Market Revenue and Forecast
8.1.9. Others
8.1.9.1. Market Revenue and Forecast
9.1. Diagnostic Testing Market, by Approach
9.1.1. Molecular Diagnostic Instrument
9.1.1.1. Market Revenue and Forecast
9.1.2. In-Vitro Diagnostic Instrument
9.1.2.1. Market Revenue and Forecast
9.1.3. Point Of Care Testing Instrument
9.1.3.1. Market Revenue and Forecast
10.1. Diagnostic Testing Market, by Solution
10.1.1. Services
10.1.1.1. Market Revenue and Forecast
10.1.2. Products
10.1.2.1. Market Revenue and Forecast
11.1. Diagnostic Testing Market, by Technology
11.1.1. Immunoassay-Based
11.1.1.1. Market Revenue and Forecast
11.1.2. PCR-Based
11.1.2.1. Market Revenue and Forecast
11.1.3. Next-generation Sequencing
11.1.3.1. Market Revenue and Forecast
11.1.4. Spectroscopy-Based
11.1.4.1. Market Revenue and Forecast
11.1.5. Chromatography-Based
11.1.5.1. Market Revenue and Forecast
11.1.6. Microfluidics
11.1.6.1. Market Revenue and Forecast
11.1.7. Substrate Technology
11.1.7.1. Market Revenue and Forecast
11.1.8. Others
11.1.8.1. Market Revenue and Forecast
12.1. Diagnostic Testing Market, by Mode of Testing
12.1.1. Prescription Based Testing
12.1.1.1. Market Revenue and Forecast
12.1.2. OTC Testing
12.1.2.1. Market Revenue and Forecast
13.1. Diagnostic Testing Market, by Sample Type
13.1.1. Urine
13.1.1.1. Market Revenue and Forecast
13.1.2. Saliva
13.1.2.1. Market Revenue and Forecast
13.1.3. Blood
13.1.3.1. Market Revenue and Forecast
13.1.4. Hair
13.1.4.1. Market Revenue and Forecast
13.1.5. Sweat
13.1.5.1. Market Revenue and Forecast
13.1.6. Others
13.1.6.1. Market Revenue and Forecast
14.1. Diagnostic Testing Market, by Testing Type
14.1.1. Biochemistry
14.1.1.1. Market Revenue and Forecast
14.1.2. Hematology
14.1.2.1. Market Revenue and Forecast
14.1.3. Microbiology
14.1.3.1. Market Revenue and Forecast
14.1.4. Histopathology
14.1.4.1. Market Revenue and Forecast
14.1.5. Others
14.1.5.1. Market Revenue and Forecast
15.1. Diagnostic Testing Market, by Age
15.1.1. Pediatric
15.1.1.1. Market Revenue and Forecast
15.1.2. Adult & Geriatric
15.1.2.1. Market Revenue and Forecast
16.1. Diagnostic Testing Market, by Distribution Channel
16.1.1. Direct Tenders
16.1.1.1. Market Revenue and Forecast
16.1.2. Retail Sales
16.1.2.1. Market Revenue and Forecast
16.1.3. Online Sales
16.1.3.1. Market Revenue and Forecast
17.1. Diagnostic Testing Market, by End User
17.1.1. Hospitals, Diagnostic Center
17.1.1.1. Market Revenue and Forecast
17.1.2. Research Labs and Institutes
17.1.2.1. Market Revenue and Forecast
17.1.3. Research Institute
17.1.3.1. Market Revenue and Forecast
17.1.4. Homecare
17.1.4.1. Market Revenue and Forecast
17.1.5. Blood Banks
17.1.5.1. Market Revenue and Forecast
17.1.6. Specialty Clinics
17.1.6.1. Market Revenue and Forecast
17.1.7. Ambulatory Surgical Centers
17.1.7.1. Market Revenue and Forecast
17.1.8. Others
17.1.8.1. Market Revenue and Forecast
18.1. North America
18.1.1. Market Revenue and Forecast, by Type
18.1.2. Market Revenue and Forecast, by Application
18.1.3. Market Revenue and Forecast, by Approach
18.1.4. Market Revenue and Forecast, by Solution
18.1.5. Market Revenue and Forecast, by Technology
18.1.6. Market Revenue and Forecast, by Sample Type
18.1.7. Market Revenue and Forecast, by Mode of Testing
18.1.8. Market Revenue and Forecast, by Testing Type
18.1.9. Market Revenue and Forecast, by Age
18.1.10. Market Revenue and Forecast, by Distribution Channel
18.1.11. Market Revenue and Forecast, by End User
18.1.12. U.S.
18.1.12.1. Market Revenue and Forecast, by Type
18.1.12.2. Market Revenue and Forecast, by Application
18.1.12.3. Market Revenue and Forecast, by Approach
18.1.12.4. Market Revenue and Forecast, by Solution
18.1.12.5. Market Revenue and Forecast, by Technology
18.1.12.6. Market Revenue and Forecast, by Sample Type
18.1.12.7. Market Revenue and Forecast, by Mode of Testing
18.1.12.8. Market Revenue and Forecast, by Testing Type
18.1.12.9. Market Revenue and Forecast, by Age
18.1.12.10. Market Revenue and Forecast, by Distribution Channel
18.1.12.11. Market Revenue and Forecast, by End User
18.1.12.12. Market Revenue and Forecast, by December
18.1.12.13. Market Revenue and Forecast, by Eleven
18.1.13. Rest of North America
18.1.13.1. Market Revenue and Forecast, by Type
18.1.13.2. Market Revenue and Forecast, by Application
18.1.13.3. Market Revenue and Forecast, by Approach
18.1.13.4. Market Revenue and Forecast, by Solution
18.1.13.5. Market Revenue and Forecast, by Technology
18.1.13.6. Market Revenue and Forecast, by Sample Type
18.1.13.7. Market Revenue and Forecast, by Mode of Testing
18.1.13.8. Market Revenue and Forecast, by Testing Type
18.1.13.9. Market Revenue and Forecast, by Age
18.1.13.10. Market Revenue and Forecast, by Distribution Channel
18.1.13.11. Market Revenue and Forecast, by End User
18.2. Europe
18.2.1. Market Revenue and Forecast, by Type
18.2.2. Market Revenue and Forecast, by Application
18.2.3. Market Revenue and Forecast, by Approach
18.2.4. Market Revenue and Forecast, by Solution
18.2.5. Market Revenue and Forecast, by Technology
18.2.6. Market Revenue and Forecast, by Sample Type
18.2.7. Market Revenue and Forecast, by Mode of Testing
18.2.8. Market Revenue and Forecast, by Testing Type
18.2.9. Market Revenue and Forecast, by Age
18.2.10. Market Revenue and Forecast, by Distribution Channel
18.2.11. Market Revenue and Forecast, by End User
18.2.12. UK
18.2.12.1. Market Revenue and Forecast, by Type
18.2.12.2. Market Revenue and Forecast, by Application
18.2.12.3. Market Revenue and Forecast, by Approach
18.2.12.4. Market Revenue and Forecast, by Solution
18.2.12.5. Market Revenue and Forecast, by Technology
18.2.12.6. Market Revenue and Forecast, by Sample Type
18.2.12.7. Market Revenue and Forecast, by Mode of Testing
18.2.12.8. Market Revenue and Forecast, by Testing Type
18.2.12.9. Market Revenue and Forecast, by Age
18.2.12.10. Market Revenue and Forecast, by Distribution Channel
18.2.12.11. Market Revenue and Forecast, by End User
18.2.13. Germany
18.2.13.1. Market Revenue and Forecast, by Type
18.2.13.2. Market Revenue and Forecast, by Application
18.2.13.3. Market Revenue and Forecast, by Approach
18.2.13.4. Market Revenue and Forecast, by Solution
18.2.13.5. Market Revenue and Forecast, by Technology
18.2.13.6. Market Revenue and Forecast, by Sample Type
18.2.13.7. Market Revenue and Forecast, by Mode of Testing
18.2.13.8. Market Revenue and Forecast, by Testing Type
18.2.13.9. Market Revenue and Forecast, by Age
18.2.13.10. Market Revenue and Forecast, by Distribution Channel
18.2.13.11. Market Revenue and Forecast, by End User
18.2.14. France
18.2.14.1. Market Revenue and Forecast, by Type
18.2.14.2. Market Revenue and Forecast, by Application
18.2.14.3. Market Revenue and Forecast, by Approach
18.2.14.4. Market Revenue and Forecast, by Solution
18.2.14.5. Market Revenue and Forecast, by Technology
18.2.14.6. Market Revenue and Forecast, by Sample Type
18.2.14.7. Market Revenue and Forecast, by Mode of Testing
18.2.14.8. Market Revenue and Forecast, by Testing Type
18.2.14.9. Market Revenue and Forecast, by Age
18.2.14.10. Market Revenue and Forecast, by Distribution Channel
18.2.14.11. Market Revenue and Forecast, by End User
18.2.15. Rest of Europe
18.2.15.1. Market Revenue and Forecast, by Type
18.2.15.2. Market Revenue and Forecast, by Application
18.2.15.3. Market Revenue and Forecast, by Approach
18.2.15.4. Market Revenue and Forecast, by Solution
18.2.15.5. Market Revenue and Forecast, by Technology
18.2.15.6. Market Revenue and Forecast, by Sample Type
18.2.15.7. Market Revenue and Forecast, by Mode of Testing
18.2.15.8. Market Revenue and Forecast, by Testing Type
18.2.15.9. Market Revenue and Forecast, by Age
18.2.15.10. Market Revenue and Forecast, by Distribution Channel
18.2.15.11. Market Revenue and Forecast, by End User
18.3. APAC
18.3.1. Market Revenue and Forecast, by Type
18.3.2. Market Revenue and Forecast, by Application
18.3.3. Market Revenue and Forecast, by Approach
18.3.4. Market Revenue and Forecast, by Solution
18.3.5. Market Revenue and Forecast, by Technology
18.3.6. Market Revenue and Forecast, by Sample Type
18.3.7. Market Revenue and Forecast, by Mode of Testing
18.3.8. Market Revenue and Forecast, by Testing Type
18.3.9. Market Revenue and Forecast, by Age
18.3.10. Market Revenue and Forecast, by Distribution Channel
18.3.11. Market Revenue and Forecast, by End User
18.3.12. India
18.3.12.1. Market Revenue and Forecast, by Type
18.3.12.2. Market Revenue and Forecast, by Application
18.3.12.3. Market Revenue and Forecast, by Approach
18.3.12.4. Market Revenue and Forecast, by Solution
18.3.12.5. Market Revenue and Forecast, by Technology
18.3.12.6. Market Revenue and Forecast, by Sample Type
18.3.12.7. Market Revenue and Forecast, by Mode of Testing
18.3.12.8. Market Revenue and Forecast, by Testing Type
18.3.12.9. Market Revenue and Forecast, by Age
18.3.12.10. Market Revenue and Forecast, by Distribution Channel
18.3.12.11. Market Revenue and Forecast, by End User
18.3.13. China
18.3.13.1. Market Revenue and Forecast, by Type
18.3.13.2. Market Revenue and Forecast, by Application
18.3.13.3. Market Revenue and Forecast, by Approach
18.3.13.4. Market Revenue and Forecast, by Solution
18.3.13.5. Market Revenue and Forecast, by Technology
18.3.13.6. Market Revenue and Forecast, by Sample Type
18.3.13.7. Market Revenue and Forecast, by Mode of Testing
18.3.13.8. Market Revenue and Forecast, by Testing Type
18.3.13.9. Market Revenue and Forecast, by Age
18.3.13.10. Market Revenue and Forecast, by Distribution Channel
18.3.13.11. Market Revenue and Forecast, by End User
18.3.14. Japan
18.3.14.1. Market Revenue and Forecast, by Type
18.3.14.2. Market Revenue and Forecast, by Application
18.3.14.3. Market Revenue and Forecast, by Approach
18.3.14.4. Market Revenue and Forecast, by Solution
18.3.14.5. Market Revenue and Forecast, by Technology
18.3.14.6. Market Revenue and Forecast, by Sample Type
18.3.14.7. Market Revenue and Forecast, by Mode of Testing
18.3.14.8. Market Revenue and Forecast, by Testing Type
18.3.14.9. Market Revenue and Forecast, by Age
18.3.14.10. Market Revenue and Forecast, by Distribution Channel
18.3.14.11. Market Revenue and Forecast, by End User
18.3.15. Rest of APAC
18.3.15.1. Market Revenue and Forecast, by Type
18.3.15.2. Market Revenue and Forecast, by Application
18.3.15.3. Market Revenue and Forecast, by Approach
18.3.15.4. Market Revenue and Forecast, by Solution
18.3.15.5. Market Revenue and Forecast, by Technology
18.3.15.6. Market Revenue and Forecast, by Sample Type
18.3.15.7. Market Revenue and Forecast, by Mode of Testing
18.3.15.8. Market Revenue and Forecast, by Testing Type
18.3.15.9. Market Revenue and Forecast, by Age
18.3.15.10. Market Revenue and Forecast, by Distribution Channel
18.3.15.11. Market Revenue and Forecast, by End User
18.4. MEA
18.4.1. Market Revenue and Forecast, by Type
18.4.2. Market Revenue and Forecast, by Application
18.4.3. Market Revenue and Forecast, by Approach
18.4.4. Market Revenue and Forecast, by Solution
18.4.5. Market Revenue and Forecast, by Technology
18.4.6. Market Revenue and Forecast, by Sample Type
18.4.7. Market Revenue and Forecast, by Mode of Testing
18.4.8. Market Revenue and Forecast, by Testing Type
18.4.9. Market Revenue and Forecast, by Age
18.4.10. Market Revenue and Forecast, by Distribution Channel
18.4.11. Market Revenue and Forecast, by End User
18.4.12. GCC
18.4.12.1. Market Revenue and Forecast, by Type
18.4.12.2. Market Revenue and Forecast, by Application
18.4.12.3. Market Revenue and Forecast, by Approach
18.4.12.4. Market Revenue and Forecast, by Solution
18.4.12.5. Market Revenue and Forecast, by Technology
18.4.12.6. Market Revenue and Forecast, by Sample Type
18.4.12.7. Market Revenue and Forecast, by Mode of Testing
18.4.12.8. Market Revenue and Forecast, by Testing Type
18.4.12.9. Market Revenue and Forecast, by Age
18.4.12.10. Market Revenue and Forecast, by Distribution Channel
18.4.12.11. Market Revenue and Forecast, by End User
18.4.13. North Africa
18.4.13.1. Market Revenue and Forecast, by Type
18.4.13.2. Market Revenue and Forecast, by Application
18.4.13.3. Market Revenue and Forecast, by Approach
18.4.13.4. Market Revenue and Forecast, by Solution
18.4.13.5. Market Revenue and Forecast, by Technology
18.4.13.6. Market Revenue and Forecast, by Sample Type
18.4.13.7. Market Revenue and Forecast, by Mode of Testing
18.4.13.8. Market Revenue and Forecast, by Testing Type
18.4.13.9. Market Revenue and Forecast, by Age
18.4.13.10. Market Revenue and Forecast, by Distribution Channel
18.4.13.11. Market Revenue and Forecast, by End User
18.4.14. South Africa
18.4.14.1. Market Revenue and Forecast, by Type
18.4.14.2. Market Revenue and Forecast, by Application
18.4.14.3. Market Revenue and Forecast, by Approach
18.4.14.4. Market Revenue and Forecast, by Solution
18.4.14.5. Market Revenue and Forecast, by Technology
18.4.14.6. Market Revenue and Forecast, by Sample Type
18.4.14.7. Market Revenue and Forecast, by Mode of Testing
18.4.14.8. Market Revenue and Forecast, by Testing Type
18.4.14.9. Market Revenue and Forecast, by Age
18.4.14.10. Market Revenue and Forecast, by Distribution Channel
18.4.14.11. Market Revenue and Forecast, by End User
18.4.15. Rest of MEA
18.4.15.1. Market Revenue and Forecast, by Type
18.4.15.2. Market Revenue and Forecast, by Application
18.4.15.3. Market Revenue and Forecast, by Approach
18.4.15.4. Market Revenue and Forecast, by Solution
18.4.15.5. Market Revenue and Forecast, by Technology
18.4.15.6. Market Revenue and Forecast, by Sample Type
18.4.15.7. Market Revenue and Forecast, by Mode of Testing
18.4.15.8. Market Revenue and Forecast, by Testing Type
18.4.15.9. Market Revenue and Forecast, by Age
18.4.15.10. Market Revenue and Forecast, by Distribution Channel
18.4.15.11. Market Revenue and Forecast, by End User
18.5. Latin America
18.5.1. Market Revenue and Forecast, by Type
18.5.2. Market Revenue and Forecast, by Application
18.5.3. Market Revenue and Forecast, by Approach
18.5.4. Market Revenue and Forecast, by Solution
18.5.5. Market Revenue and Forecast, by Technology
18.5.6. Market Revenue and Forecast, by Sample Type
18.5.7. Market Revenue and Forecast, by Mode of Testing
18.5.8. Market Revenue and Forecast, by Testing Type
18.5.9. Market Revenue and Forecast, by Age
18.5.10. Market Revenue and Forecast, by Distribution Channel
18.5.11. Market Revenue and Forecast, by End User
18.5.12. Brazil
18.5.12.1. Market Revenue and Forecast, by Type
18.5.12.2. Market Revenue and Forecast, by Application
18.5.12.3. Market Revenue and Forecast, by Approach
18.5.12.4. Market Revenue and Forecast, by Solution
18.5.12.5. Market Revenue and Forecast, by Technology
18.5.12.6. Market Revenue and Forecast, by Sample Type
18.5.12.7. Market Revenue and Forecast, by Mode of Testing
18.5.12.8. Market Revenue and Forecast, by Testing Type
18.5.12.9. Market Revenue and Forecast, by Age
18.5.12.10. Market Revenue and Forecast, by Distribution Channel
18.5.12.11. Market Revenue and Forecast, by End User
18.5.13. Rest of LATAM
18.5.13.1. Market Revenue and Forecast, by Type
18.5.13.2. Market Revenue and Forecast, by Application
18.5.13.3. Market Revenue and Forecast, by Approach
18.5.13.4. Market Revenue and Forecast, by Solution
18.5.13.5. Market Revenue and Forecast, by Technology
18.5.13.6. Market Revenue and Forecast, by Sample Type
18.5.13.7. Market Revenue and Forecast, by Mode of Testing
18.5.13.8. Market Revenue and Forecast, by Testing Type
18.5.13.9. Market Revenue and Forecast, by Age
18.5.13.10. Market Revenue and Forecast, by Distribution Channel
18.5.13.11. Market Revenue and Forecast, by End User
19.1. F-Hoffman La-Rcohe Ltd. (Switzerland)
19.1.1. Company Overview
19.1.2. Product Offerings
19.1.3. Financial Performance
19.1.4. Recent Initiatives
19.2. Danaher (US)
19.2.1. Company Overview
19.2.2. Product Offerings
19.2.3. Financial Performance
19.2.4. Recent Initiatives
19.3. BD (US)
19.3.1. Company Overview
19.3.2. Product Offerings
19.3.3. Financial Performance
19.3.4. Recent Initiatives
19.4. Thermo Fisher Scientific Inc. (US)
19.4.1. Company Overview
19.4.2. Product Offerings
19.4.3. Financial Performance
19.4.4. Recent Initiatives
19.5. ACON Laboratories Inc. (US)
19.5.1. Company Overview
19.5.2. Product Offerings
19.5.3. Financial Performance
19.5.4. Recent Initiatives
19.6. Hemosure, Inc. (US)
19.6.1. Company Overview
19.6.2. Product Offerings
19.6.3. Financial Performance
19.6.4. Recent Initiatives
19.7. MicroGen Diagnostics (US)
19.7.1. Company Overview
19.7.2. Product Offerings
19.7.3. Financial Performance
19.7.4. Recent Initiatives
19.8. Grifols, S.A (Spain)
19.8.1. Company Overview
19.8.2. Product Offerings
19.8.3. Financial Performance
19.8.4. Recent Initiatives
19.9. BODITECH MED INC. (South Korea)
19.9.1. Company Overview
19.9.2. Product Offerings
19.9.3. Financial Performance
19.9.4. Recent Initiatives
19.10. Chembio Diagnostic Systems, Inc. (US)
19.10.1. Company Overview
19.10.2. Product Offerings
19.10.3. Financial Performance
19.10.4. Recent Initiatives
20.1. Primary Research
20.2. Secondary Research
20.3. Assumptions
21.1. About Us
21.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample